ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,314Medicare Part D Prescriptions Filled, Including Refills

Rank: 140 out of 680

$648K Total Retail Price of All Prescriptions

Rank: 185 out of 680

475 Patients Receiving at Least One Drug in Part D
50%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

18% of this provider’s 475 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

5% of this provider’s 7,673 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
TRAMADOL HCL 503 281 1 18
AMLODIPINE BESYLATE 494 344 2 1
METFORMIN HCL 442 211 3 8
FUROSEMIDE 381 240 4 6
SIMVASTATIN 342 219 5 3
PRAVASTATIN SODIUM 341 186 6 10
NEXIUM 331 154 7 16
ZOLPIDEM TARTRATE 325 129 8 17
LISINOPRIL 316 170 9 5
HYDROCHLOROTHIAZIDE 264 159 10 9
HYDROCODONE-ACETAMINOPHEN 256 91 S3 11 4
POTASSIUM CHLORIDE 239 162 12 14
CLONIDINE HCL 229 148 13 36
WARFARIN SODIUM 188 102 14 20
OMEPRAZOLE 187 116 15 7
ATORVASTATIN CALCIUM 174 129 16 11
AMLODIPINE BESYLATE-BENAZEPRIL 174 149 16 43
METOPROLOL TARTRATE 173 129 18 12
AMOXICILLIN 169 60 19 111
METOPROLOL SUCCINATE 162 138 20 13
CLOPIDOGREL 148 102 21 26
RANITIDINE HCL 142 104 22 56
LISINOPRIL-HYDROCHLOROTHIAZIDE 141 82 23 37
BENAZEPRIL HCL 140 104 24 40
DIOVAN 133 76 25 31
CYCLOBENZAPRINE HCL 132 71 R 26 81
GLYBURIDE 128 70 R 27 85
SULFAMETHOXAZOLE-TRIMETHOPRIM 128 52 27 94
LEVOTHYROXINE SODIUM 128 65 27 2
KLOR-CON M20 122 90 30 61
ATENOLOL 121 77 31 19
GLIPIZIDE 116 53 32 63
PLAVIX 115 82 33 39
ENALAPRIL MALEATE 112 56 34 65
IBUPROFEN 112 50 34 126
TRIAMTERENE-HCTZ 111 80 36 52
LOVASTATIN 108 80 37 44
DIOVAN HCT 106 99 38 55
PHENYTOIN SODIUM EXTENDED 104 44 39 115
MELOXICAM 102 66 40 24
BYSTOLIC 97 53 41 79
LYRICA 88 54 42 77
CRESTOR 88 47 42 25
MEGESTROL ACETATE 85 70 R 44 88
DILTIAZEM HCL 79 46 45 291
LIPITOR 78 63 46 68
GABAPENTIN 72 38 47 15
PANTOPRAZOLE SODIUM 72 46 47 30
ADVAIR DISKUS 71 55 49 53
ISOSORBIDE MONONITRATE ER 70 56 50 59
TAMSULOSIN HCL 70 35 50 34
ALLOPURINOL 70 40 50 33
CARVEDILOL 69 18 53 23
FAMOTIDINE 67 44 54 89
PROPRANOLOL HCL 66 38 55 145
VERAPAMIL ER 65 33 56 100
NIFEDIPINE ER 63 37 57 75
ESCITALOPRAM OXALATE 63 26 57 45
INSULIN SYRINGE 63 27 57 86
DETROL LA 62 39 60 169
RAMIPRIL 56 34 61 69
DILTIAZEM 24HR ER 55 26 62 132
GLIMEPIRIDE 54 27 63 29
TRICOR 52 31 64 98
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 10, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.